T 0694/01 (Test device/UNILEVER) of 04.07.2002
- European Case Law Identifier
- ECLI:EP:BA:2002:T069401.20020704
- Date of decision
- 4 July 2002
- Case number
- T 0694/01
- Petition for review of
- -
- Application number
- 88303744.2
- IPC class
- G01N 33/543
- Language of proceedings
- English
- Distribution
- Published in the EPO's Official Journal (A)
- Download
- Decision in English
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Immunoassays and devices therefor
- Applicant name
- UNILEVER N. V.
- Opponent name
- (01) VEDALAB
(02) Carter-Wallace Inc.
(03) GENZYME CORPORATION
(04) Andrea von Preen
(05) Int. Mycoplasma
(06) Technical Chemicals & Products Inc.
(08) ORAMON Arzneimittel GmbH
(09) Pharma Peter
(10) ulti med Products (Deutschland)
(11) Cardimac Gesellschaft für Diagnostische Schnellteste mbH - Board
- 3.3.04
- Headnote
An intervention is dependent on the extent to which opposition/appeal proceedings are still pending.
Where a board has decided that a patent be maintained on the basis of a given set of claims and a description to be adapted thereto, in subsequent appeal proceedings confined to the issue of the adaption of the description, the intervener cannot challenge the res judicata effect of the previous board of appeal decision by introducing a new ground for opposition.
- Relevant legal provisions
- European Patent Convention Art 105 1973
- Keywords
- Intervention during pending appeal proceedings - admissibility (yes)
New ground of opposition - void
Scope of appeal limited to adaption of description
Claims - res judicata - Catchword
- -
ORDER
For these reasons it is decided that:
1. The requests for referral of questions of law to the Enlarged Board of Appeal are refused.
2. The appeals and the intervention are dismissed.